Immunisation with gp160 in HIV-1 infection

Lancet. 1999 Sep 11;354(9182):948-9. doi: 10.1016/S0140-6736(05)75694-4.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / immunology*
  • Anti-HIV Agents / administration & dosage
  • Combined Modality Therapy
  • HIV Envelope Protein gp160 / immunology*
  • HIV Infections / immunology*
  • HIV Infections / therapy
  • HIV-1 / immunology*
  • Humans
  • Treatment Outcome
  • Vaccines, Synthetic / administration & dosage
  • Vaccines, Synthetic / immunology*

Substances

  • AIDS Vaccines
  • Anti-HIV Agents
  • HIV Envelope Protein gp160
  • Vaccines, Synthetic